Background and purpose: integrated care pathways are often implemented to guide acute stroke therapy and improve organisation of care, but there is not sufficient evidence to support their routine use. We sought to evaluate the effects of introducing an integrated care pathway for acute stroke. Methods: we performed a before-and-after study. The 'before' (control) group comprised 154 consecutive stroke patients admitted to the acute stroke unit over a 9-month period. The 'after' (intervention) group comprised 197 consecutive patients admitted to the same unit over a 9-month period in the year after the introduction of the integrated care pathway. Effectiveness was assessed with a variety of measures: quality of documentation; process of care; occurrence of complications; death and discharge destination. Results were adjusted for case mix using a validated model. Results: the baseline characteristics of the two groups were similar, although there were more total anterior circulation strokes (29% versus 18%, P = 0.005) and fewer partial anterior circulation strokes (30% versus 42% P = 0.04) in the intervention group. In the intervention group, we found that urinary tract infections were significantly less frequent (OR 0.37, CI 0.15-0.91) and the quality of several aspects of care (e.g. CT scanning <48 hours) and documentation were significantly better. However, there were no significant differences in deaths, discharge destination, or length of stay between the two groups. Conclusion: this before-and-after study has provided further evidence that introducing an integrated care pathway for acute stroke may improve the quality of documentation and process of care, and reduce the risk of certain post-stroke complications.
Introduction
Organised stroke unit care improves outcome in patients recovering from an acute stroke [1] . Across the world, integrated care pathways (ICPs) are increasingly being implemented for the management of stroke patients [2] [3] [4] [5] [6] . An ICP can be defined as a plan of care that aims to promote organised and efficient multidisciplinary patient care that is based on the best available evidence and guidelines. It usually forms all or part of the patient record and it focuses on the practical delivery of patient care with prompts to highlight important interventions. It is intended to assist healthcare professionals to achieve pre-specified patient goals efficiently while improving the quality of care [7] .
Is there sufficient evidence to support their use for stroke care? A recent Cochrane review found that, compared with 'standard care', the use of ICPs for stroke may be associated with both positive and negative impact on patient care [7] . On the one hand, evidence from mainly non-randomised trials showed that patients managed using an ICP for acute stroke may be less likely to suffer urinary tract infections or be readmitted, and they may be more likely to have computed tomography (CT) or carotid duplex scanning [7] . On the other hand, evidence from randomised trials suggests that patient satisfaction and quality of life may be lower amongst patients managed with an ICP for stroke rehabilitation [7] . Overall, the balance of risk and benefit remains unclear. In our hospital, an ICP for acute stroke was introduced into our well-established acute stroke unit in March 2001. We performed a study to evaluate the effects of introducing this ICP.
Methods

Study design
We employed a before-and-after study design to compare patient outcome and process of care between two groups of stroke patients: (i) the intervention group, which comprised prospectively identified patients admitted after the introduction of the ICP; and (ii) the control group, which comprised retrospectively identified patients admitted before its introduction.
Participants and their assessments
For the intervention group, we included consecutive stroke patients admitted to the acute stroke unit between July 2000 and April 2001 (a 9-month period after the introduction of the ICP). For the control group, we included consecutive patients admitted to the same unit between May 1999 and February 2000 (a 9-month period before the introduction of the ICP). For the intervention group, every identified patient was assessed on the day of admission (or as soon after admission as possible) and clinical data extracted from the case notes on day 5. For the control group, clinical data were extracted from case notes.
Outcome measures
These included: (i) quality of documentation; (ii) process of care during the first 5 days, including documented use of investigations, medications, rehabilitative therapy and nursing interventions, and length of stay; (iii) occurrence of complications during the first 5 days (as defined in Langhorne et al. [8] ); and (iv) death and discharge destination (by day 5 and at the end of hospitalisation). The first 5 days were chosen because the ICP was designed for use during the first 5 days.
Statistical methods
Statistical analyses were carried out using SPSS for Windows (version 11, SPSS Inc., 2002 ). An intention-to-treat approach was used to analyse the data, i.e. we included all eligible patients admitted to the unit in the intervention group whether or not the ICP was actually used in their case. For comparisons of dichotomous outcomes, we calculated the odds ratios (OR) with their 95% confidence intervals (CI). We used Yates-corrected Chi-square test and Fisher's exact test to calculate the exact P values. For outcomes with continuous data, we first checked the data for normality of distribution. For normally distributed data, comparisons of means were performed using an independent t-test; otherwise, the non-parametric Mann-Whitney U test was used. For outcome measures that could be influenced by case mix, we adjusted the data using logistic regression and employed a well validated prognostic model [9] .
The acute stroke unit and ICP
The acute stroke unit comprised a 10-bedded unit situated within a 25-bedded elderly care ward. Medical cover was provided by two stroke specialist consultants, one senior and one junior medical officer. The nurse-to-bed ratio was between 0.15 (night shift) and 0.27 (early shift). Rehabilitative therapy was provided by 1.5 whole time equivalent (WTE) physiotherapist, 1.5 WTE occupational therapist, 0.5 WTE speech therapist, a dietician and a social worker. Patients' progress was discussed at the weekly multidisciplinary team meetings. Before the introduction of the ICP, documentation of patient care was not guided by a stroke-specific clerking proforma but the doctors used a generic medical admission proforma (for all medical conditions). There was also no specific guidance for the medical or nursing management of stroke patients during the first few days of admission. The organisation of care between the two phases of the study did not change, except for the appointment of an extra physiotherapist.
The ICP was a multidisciplinary patient record developed by the stroke team to guide patient care during the first 5 days of admission. The introductory process, which lasted 6 months, consisted of review of research evidence and clinical guidelines, design of the ICP document, and its implementation on the stroke unit (including training sessions for the staff). The ICP document comprised three sections: doctors', nurses' and therapists' sections. The ICP, which consisted of check-lists, aimed to improve the quality of documentation and process of care, enhance communication between disciplines, reduce post-stroke complications, and possibly improve functional outcomes. On admission, the initial assessments were guided by the doctor's clerking proforma [10] , nursing and therapy assessment forms, and various assessment tools (e.g. to determine the risk of pressure sores, nutritional status, and swallowing ability). For the first 5 days, the staff followed treatment algorithms to guide acute stroke care, including the management of common medical problems such as fever, hypoxia and hyperglycaemia. The ICP used in this study is available from the authors.
Assessment of compliance with the ICP
We assessed compliance in two ways: (ii) whether the different sections of the ICP were used; and (ii) if the sections were used, the level of completeness of the recording.
Results
Baseline characteristics (see Table 1 )
We prospectively identified 318 potential acute stroke patients in the intervention group and 202 potential controls. Of the 318 potential patients in the intervention group, we excluded 33 patients who had non-stroke conditions and 88 who were admitted to general medical wards, leaving 197 patients for analysis. Of the 202 potential controls, we excluded four who were transferred to the unit more than 5 days after admission, 12 whose case notes were missing, and 32 with non-stroke conditions, leaving 154 controls for analysis.
The mean age (standard deviation, SD) was 74.5 (11.7) years in the intervention group and 74.5 (12.2) years in the control group. The two groups were similar for most of the clinical characteristics assessed (see Table 1 ) except that the intervention group had more total anterior circulation strokes (TACS, 29% versus 18%, P=0.005) and fewer partial anterior circulation strokes (PACS, 30% versus 42%, P = 0.04).
Compliance with the ICP document
In the intervention group, the relevant sections had been used by doctors in 147/197 patients (74%), by nurses in 145 (73%), and by both the doctors and nurses in 129 (65%). Every item of the ICP was completed in 97/147 (66%) of the doctors' sections and 82/145 (57%) of the nurses' sections.
Outcome measures
Quality of documentation
Documentation of the clinical assessment was significantly more thorough in the intervention group in terms of: sensation (OR 1.80, CI 1.16-2.80, P = 0.01); truncal control or gait (OR 8.11, CI 4.96-13.25, P < 0.0001); assessment of mental ability (OR 2.50, CI 1.57-3.98, P = 0.0001); and swallowing (OR 1.70, CI 1.09-2.65, P = 0.03). Similarly, documentation of the diagnostic description was significantly more thorough for the anatomical site of the lesion (OR 3.73, CI 2.28-6.09, P < 0.0001) and the pathological subtype of stroke (OR 2.46, CI 1.56-3.88, P = 0.0002). Table 2 ) A. Use of investigations. After adjusting for case mix, the patients in the intervention group were more likely to have a CT brain scan within 24 hours (OR 1.84, CI 1.09-3.10, P = 0.02), and within 48 hours (OR 2.27, CI 1.13-4.55, P = 0.02). There were no significant differences in the performance of other investigations. B. Use of medications. There were no significant differences in the use of various medications between the two groups. C. Use of rehabilitative therapy and nursing interventions. After adjusting for case mix, patients in the intervention group were more likely to receive physiotherapy (OR 2.53, CI 1.58-4.04, P = 0.0005), but an extra physiotherapist had been appointed between the two phases of the study. There were no significant differences in the provision of other types of therapy or various nursing interventions. D. Total length of stay. There was no significant difference in the median length of stay between the two groups (intervention group 10 days versus control group 8 days, P = 0.65, Mann-Whitney U test). The maximum lengths of stay were 164 days and 96 days, respectively. Table 3 )
Process of care during the first 5 days (see
Occurrence of complications during the first 5 days (see
After adjusting for case mix, we found that patients in the intervention group were less likely to have urinary tract infections (OR 0.37, CI 0.15-0.91, P = 0.03). There were no significant differences in the occurrence of other complications.
Death and discharge destination (Table 3)
After adjusting for case mix, we found no significant differences between the two groups in the proportions of patients who died, who were discharged to an institution, or discharged to home (by day 5 or at the end of hospitalisation).
Influence of compliance on results
To evaluate this, we also analysed the data using treatmentreceived analysis, comparing the controls with those patients who had the relevant sections of the ICP used. This analysis should assess the maximal effects of the ICP since those patients who were not managed using the ICP would be excluded. The results derived from this analysis were similar to those from intention-to-treat analysis, indicating that compliance did not have a substantial impact on the results.
Discussion
Interpretation of results
The introduction of the ICP was associated with fewer urinary tract infections, which is consistent with earlier observational studies [3, 5, 11, 12] . This might be related to the trend toward fewer catheterisations in the intervention group (adjusted OR 0.58, not statistically significant), but other factors such as better nursing care or earlier removal of catheters may also be responsible, although these were not examined in the present study. Our finding of improvement in certain aspects of care is also consistent with those of the Cochrane review and other more recently published reports [7, 13, 14] . Like many previous studies, we did not find evidence of an effect on death or discharge destination [2, 5, 12, [15] [16] [17] . This is perhaps not surprising because: (i) the sample size was small and confidence intervals were wide, hence a modest effect could not be excluded; and (ii) patient care in the unit was already well organised and it would be difficult to show a mortality benefit over and above this level of care. In the present study, we assessed mortality by the end of hospitalisation, the results of which could have been confounded by factors such as length of stay and the occurrence of hospitalacquired complications. A more robust outcome measure would have been the 30-day case fatality rate. However, it might perhaps be too optimistic to expect the introduction of an ICP to affect the risk of death or discharge destination, but since one of the aims of introducing the ICP was to improve the organisation of care, it could perhaps be regarded as complementary to stroke unit care, which has been proven to reduce the risk of being dead or disabled.
We found that it was not the use of the ICP, but the introduction of the ICP, that appeared to be responsible for the observed effects. This could be because the process of designing and implementing the ICP also involved numerous other activities which might influence patient care, such as review of research evidence, audit of current practice (with identification of strengths and weaknesses), open discussions, and team-building. Other factors that might also (indirectly) influence patient care include the process of implementation (e.g. sense of ownership, staff's acceptance) and post-implementation support (e.g. regular feedback and support). On the whole, 'ICP care' could be regarded as a complex intervention as defined by the Medical Research Council, i.e. one that is made up of several components which are inter-dependent in their functions [18] .
Methodological difficulties in evaluating ICPs
The present study illustrates the many methodological difficulties in evaluating ICPs. Most importantly, the present study was not a randomised controlled trial (RCT). There are several major reasons why unbiased and unconfounded RCTs are difficult to perform when assessing the effects of ICPs. These include: (i) both the active and control interventions are usually complex in nature; (ii) large numbers of patients are needed to reliably detect a moderate effect; (iii) researchers may be reluctant to randomise patients because of pre-formed opinions about the intervention; (iv) patients and carers may not want to participate because of pre-formed opinions about the intervention; (v) it is difficult to blind the healthcare professionals and assessors of outcome; and (vi) active and control interventions might 'cross-contaminate' when individual patients are randomised because they are usually managed by the same staff within the same unit.
Non-randomised studies are therefore more commonly performed, but they are affected by biases and confounding factors which reduce the validity of the results. In the present study, the most obvious bias stems from the retrospective data extraction from case notes. The occurrence of a particular outcome was only recorded if it had been documented, which means the accuracy of the results was dependent on the quality of documentation. Furthermore, the assessor in this study was not blinded to the intervention, which might have resulted in observer bias [19] . The stroke unit staff were also aware of the study being conducted so they might have managed patients or documented their care in a different manner, possibly leading to biased results. However, the staff were not reminded of this during the study.
One major confounding factor in the present study is the apparent difference in the proportions of patients presenting with TACS and PACS between two groups. This is likely to be a spurious finding because there was no significant difference in the unadjusted outcomes between the two groups, and the adjustment for case mix had made no substantial impact on the results. Other potential confounding factors include differences in the level of staffing and training, publication of national guidelines for stroke, and seasonal variations in outcomes.
Future studies could explore the effects of this complex organisational intervention on other important outcomes such as communication, patient satisfaction and cost of care. It should be borne in mind that most clinical studies of ICPs, even RCTs, are likely to be affected by biases and confounding factors.
Key points
• The benefits of ICPs for acute stroke are not yet proven.
• We conducted a before-and-after study to evaluate the effects of introducing an ICP in an acute stroke unit.
• The introduction of the ICP was associated with improvement in certain aspects of patient care and reduced risk of urinary tract infections, but there was no evidence of an effect on functional outcome or length of stay.
• ICPs are a complex organisational intervention with many components which are inter-dependent in their functions and effects.
• Most clinical studies of ICPs, even RCTs, are likely to be affected by biases and confounding factors.
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